Compounds > 2,3-bis(4-hydroxyphenyl)-propionitrile
Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and Leukemia, Lymphocytic, Chronic, B-Cell

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasni, MS; Yakimchuk, K1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
Expression and Effects of Ligand-activated Estrogen Receptors in Chronic Lymphocytic Leukemia.
    Anticancer research, 2019, Volume: 39, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ligands; Nitriles; Protein Binding; Protein Isoforms; RNA, Messenger

2019